APOP Cellect Biotechnology Ltd. ADRs

Cellect Biotechnology Ltd is an emerging biotechnology company engaged in developing a novel technology platform known as Powered by Cellect that functionally selects stem cells from a mixed population of cells in order to improve the safety and efficacy. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$6.50  +0.16 (2.52%)
As of 09/17/2021 11:16:26 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  07/29/2016
Outstanding shares:  3,909,491
Average volume:  4,384,670
Market cap:   $24,121,559
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    15116C102
ISIN:        US15116C1027
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   9.18
PS ratio:   0.00
Return on equity:   -368.76%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy